Case Western Reserve and NeoProteomics Announce Exclusive Option
Friday, March 25, 2011 - 15:31
in Biology & Nature
NeoProteomics Inc., a biomarker development and software company, has secured an exclusive option agreement with Case Western Reserve University. The deal has potential to enhance various forms of treatment of cancer, diabetes, and inflammatory diseases.